Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson's disease
Findings suggest low utilization of DATs among US Medicare beneficiaries with aPD. Even states with more DAT facilities often require patients to travel long distances. Identifying and minimizing access disparities, particularly for women, racial minorities, and people with low socioeconomic status may improve DAT utilization and outcomes for patients with aPD.
Authors
- Michael J. Soileau (ORCID: https://orcid.org/0000-0002-3944-1327)
- Joohi Jimenez‐Shahed (ORCID: https://orcid.org/0000-0002-9772-7569)
- Christie Teigland (ORCID: https://orcid.org/0000-0003-4887-8077)
- Jill Schinkel
- Connie H. Yan (ORCID: https://orcid.org/0000-0003-1467-4666)
- Irene A. Malaty (ORCID: https://orcid.org/0000-0001-6914-9223)
- Aaron Hambrick
- Megha Shah
- Hubert H. Fernandez (ORCID: https://orcid.org/0000-0002-8553-5316)
- Lakshmi Rao Kandukuri
- Pavnit Kukreja
Institutions
- Cleveland Clinic (US)
- Freddie Mac (United States) (US)
- AbbVie (United States) (US)
- University of Florida (US)
- Nova Medical (United States) (US)
- Southwestern University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Parkinsonism & Related Disorders
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1016/j.parkreldis.2025.107322
- Citations
- 7
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.72
Funders
- AbbVie